Click on a filter below to refine your search. Remove a filter to broaden your search.
No effect was seen on mean frailty scores over time or in rate of change in mean frailty score with supplementation.
Reopening does not mean the pandemic is over, and some public health measures will still be in place for ‘mega events.’
Doing so would mean that the WHO views the normally rare disease as a continuing threat to nations worldwide.
Significant differences in mean overall CVH scores were based on Life’s Essential 8 by sex, age and racial/ethnic group.
Increases also were seen in the proportion of participants with a mean monthly BP classified as uncontrolled or severely uncontrolled hypertension.
No significant difference was seen in mean weight loss at 12 months with time-restricted eating and daily calorie restriction.
Patients treated with dasatinib had a mean reduction in serum glucose concentration and a relative decrease in body weight.
In a Scottish cohort, mean frailty decreased as the Disease Activity Score in 28 joints lessened over time with treatment.
In the year following the start of dialysis, stabilization with mean changes of +2 and –2 were seen in mental and physical component summaries.
The mean length of stay and percentages admitted to the ICU, receiving invasive mechanical ventilation and dying were lower during omicron.